475 related articles for article (PubMed ID: 1309369)
1. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
[TBL] [Abstract][Full Text] [Related]
2. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.
Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Sundqvist VA; Wahren B
J Infect Dis; 1986 May; 153(5):840-7. PubMed ID: 3009635
[TBL] [Abstract][Full Text] [Related]
3. Studies on transfer of varicella-zoster-virus specific T-cell immunity from bone marrow donor to recipient.
Kato S; Yabe H; Yabe M; Kimura M; Ito M; Tsuchida F; Tsuji K; Takahashi M
Blood; 1990 Feb; 75(3):806-9. PubMed ID: 2153426
[TBL] [Abstract][Full Text] [Related]
4. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
5. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
[TBL] [Abstract][Full Text] [Related]
6. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity to varicella-zoster virus.
Arvin AM
J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
[TBL] [Abstract][Full Text] [Related]
8. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
[TBL] [Abstract][Full Text] [Related]
9. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
10. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
[TBL] [Abstract][Full Text] [Related]
13. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.
Steain M; Sutherland JP; Rodriguez M; Cunningham AL; Slobedman B; Abendroth A
J Virol; 2014 Mar; 88(5):2704-16. PubMed ID: 24352459
[TBL] [Abstract][Full Text] [Related]
14. Detection of varicella-zoster virus in lymphocytes by DNA hybridization.
Vonsover A; Leventon-Kriss S; Langer A; Smetana Z; Zaizov R; Potaznick D; Cohen IJ; Gotlieb-Stematsky T
J Med Virol; 1987 Jan; 21(1):57-66. PubMed ID: 3025357
[TBL] [Abstract][Full Text] [Related]
15. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.
Arvin AM; Koropchak CM; Williams BR; Grumet FC; Foung SK
J Infect Dis; 1986 Sep; 154(3):422-9. PubMed ID: 3016110
[TBL] [Abstract][Full Text] [Related]
16. Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients.
Pauksen K; Sjölin J; Linde A; Andersson B; Lenkei R; Oberg G; Ljungman P
Scand J Infect Dis; 1999; 31(1):43-9. PubMed ID: 10381217
[TBL] [Abstract][Full Text] [Related]
17. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
18. Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients.
Matko S; Akgün K; Tonn T; Ziemssen T; Odendahl M
Mult Scler Relat Disord; 2020 Feb; 38():101859. PubMed ID: 31855843
[TBL] [Abstract][Full Text] [Related]
19. Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella.
Ishizaki Y; Tezuka J; Ohga S; Nomura A; Suga N; Kuromaru R; Kusuhara K; Mizuno Y; Kasuga N; Hara T
J Infect; 2003 Aug; 47(2):133-8. PubMed ID: 12860147
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
